Showing results (1-10 of 788) with videos related to

Sort By:
Pageof 79
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosineS Yerly, L Kaiser, C Baumberger, et al.
AIDS (London, England)|February 1, 1995
Response of HIV RNA to didanosine as a predictive marker of survivalS Yerly, L Kaiser, B Mermillod, et al.
The Journal of Infectious Diseases|August 1, 1992
Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parametersS Yerly, E Chamot, B Hirschel, et al.
AIDS (London, England)|November 1, 1993
High levels of circulating RNA in patients with symptomatic HIV-1 infectionC Baumberger, S Kinloch-de-Loës, S Yerly, et al.
The Journal of Infectious Diseases|November 1, 1991
Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective studyS Yerly, E Chamot, J J Déglon, et al.
The Journal of Infectious Diseases|June 1, 1996
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study GroupA Galetto-Lacour, S Yerly, T V Perneger, et al.
AIDS (London, England)|September 1, 1996
Combined therapy with zidovudine and L-697,661 in primary HIV infectionL Perrin, A Rakik, S Yerly, et al.
The Journal of Infectious Diseases|July 1, 1995
Foscarnet decreases human immunodeficiency virus RNAL Kaiser, L Perrin, B Hirschel, et al.
AIDS (London, England)|January 1, 1995
V3 sequences in primary HIV-1 infectionI M Antonioli, C Baumberger, S Yerly, et al.
Antiviral Therapy|August 1, 1996
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patientsS Yerly, N Denereaz, B Mermillod, et al.
Pageof 79